Invivyd (IVVD) Price to Earnings (2021 - 2026)
Invivyd's (IVVD) quarterly Price to Earnings came in at 5.6 in Q2 2026, up 1.19% on a YoY basis from 5.53 in Q2 2025, and up 83.48% quarter-over-quarter from 33.88 in Q4 2025.
Powered by 
Analysis
Invivyd (IVVD) Price to Earnings (2021 - 2026) Analysis & Trends
Invivyd (IVVD) has reported Price to Earnings for 6 consecutive years, with 5.6 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to Earnings rose 1.19% year-over-year to 5.6; the trailing twelve-month figure through Jun 2026 stood at 3.04 (down 304.08% YoY), and the FY2025 full-year result was 7.66, down 2468.22% from the prior year.
- Price to Earnings climbed to 5.6 in Q2 2026 per IVVD's latest filing, from 33.88 in the prior quarter.
- Across five years, Price to Earnings topped out at 1.96 in Q3 2024 and bottomed at 33.88 in Q4 2025.
- Historically, Price to Earnings has averaged 7.25 across 5 years, with a median of 4.96 in 2022.
- The sharpest annual moves came in 2022 and 2025: Price to Earnings jumped 83.2% in 2022, then tumbled 1135.57% in 2025.
- Over 5 years, Price to Earnings stood at 3.39 in 2022, then sank by 66.68% to 5.66 in 2023, then soared by 51.51% to 2.74 in 2024, then sank by 1135.57% to 33.88 in 2025, then surged by 83.48% to 5.6 in 2026.
- According to Business Quant data, Price to Earnings over the past three periods registered 5.6, 33.88, and 16.98 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.60 |
| Dec 31, 2025 | -33.88 |
| Sep 30, 2025 | -16.98 |
| Jun 30, 2025 | -5.66 |
| Mar 31, 2025 | -4.32 |
| Dec 31, 2024 | -2.74 |
| Sep 30, 2024 | -1.96 |
| Jun 30, 2024 | -2.67 |
| Mar 31, 2024 | -11.49 |
| Dec 31, 2023 | -5.66 |
| Sep 30, 2023 | -4.34 |
| Jun 30, 2023 | -2.14 |
| Mar 31, 2023 | -3.36 |
| Dec 31, 2022 | -3.39 |
| Sep 30, 2022 | -7.21 |
| Jun 30, 2022 | -6.89 |
| Mar 31, 2022 | -4.96 |
| Dec 31, 2021 | -3.72 |
| Sep 30, 2021 | -42.89 |